Defining ANDV Virulence and Attenuation Mechanisms
Defining ANDV Virulence and Attenuation Mechanisms
批准号:
10054155
负责人:
Erich R Mackow
金额:
$64.19万
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
已结题
起止时间:
2016-11-25 至 2023-10-31
关键词:
AcuteAmericanAndes VirusAttenuatedBindingBlood VesselsBlood capillariesComplexCytoplasmic TailDataDiseaseDisease modelElementsEndothelial CellsExtravasationFamily memberGenesHamstersHantavirusHantavirus InfectionsHantavirus Pulmonary SyndromeHumanIRF3 geneImmune responseInfectionInnate Immune ResponseInterferon Type IInterferon-alphaInterferonsKineticsLungMesocricetus auratusMutateMutationNonlyticPathogenicityPathway interactionsPersonsPhosphorylationPlasmidsProteinsProteomicsPulmonary EdemaRNA VirusesReassortant VirusesRegulationRenillaReporterReportingRoleSignal PathwaySignal TransductionSin Nombre virusTBK1 geneTNF receptor-associated factor 3TRIM FamilyTestingViremiaVirulenceVirus Diseasesattenuationhuman pathogenmutantnovelpreventresponsereverse geneticssensorsynergismtranscription factorvaccine candidatevaccine developmentvaccine evaluationvirtual
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Hantaviruses (HVs) predominantly infect the endothelial cell (EC) lining of capillaries and nonlytically cause
vascular leakage. Andes virus (ANDV) and Sin Nombre virus (SNV) infect virtually all pulmonary ECs(109) and
cause 35% fatal acute pulmonary edema (HV pulmonary syndrome-HPS). However, ANDV is the only HV
spread person to person and the only HV that causes lethal HPS-like disease in hamsters. Pathogenic HVs
regulate early innate immune responses in order to successfully replicate in ECs and we recently revealed that
ANDV contains an additional interferon (IFN) regulating determinant that explains unique ANDV spread and
virulence and is a potential target for attenuating ANDV.
HVs are inhibited by IFN added prior to or early after infection, and in order to replicate in human ECs
pathogenic HVs regulate early IFN induction. Nonpathogenic PHV, fails to regulate IFN induction or replicate in
human ECs, and failed IFN regulation explains why PHV is not a human pathogen. Except for PHV, HV Gn
proteins contain cytoplasmic tail (GnT) elements that inhibit RIG-I/TBK1 directed IRF3 phosphorylation and
IFNβ induction. In contrast, N proteins from TULV, SNV, NY-1V, HTNV and PHV fail to inhibit RIG-I/TBK1
directed IFN induction. Unpredictably, the ANDV N protein inhibited RIGI/TBK1 directed IFN induction. In
contrast, N protein from a nonpathogenic S. American HV, MAPV, failed to inhibit IFN signaling, yet MAPV N
differs by only 12 dissimilar residues from ANDV N.
ANDV N protein inhibits TBK1 autophosphorylation that is required for TBK1 phosphorylation of IRF3 and
our recent proteomics screen found that ANDV N binds a single IFN regulating protein in ECs, TRIM21.
Reciprocal TRIM21 IPs validated ANDV N, but not TULV N, as a TRIM21 binding partner. Preliminary data
indicates that mutating ANDV residues to MAPV N residues prevents IFN regulation and TRIM21 binding, and
provides a mechanism for attenuating ANDV. Our findings suggest that IFN regulation by the ANDV N protein
is a novel virulence determinant. This may explain why ANDV uniquely causes viremia and lethal HPS disease
in Syrian hamsters and why ANDV is the only HV spread from person to person. These findings permit us to
propose defining the role of N and Gn directed IFN regulation in attenuating ANDV and preventing lethal HPS
in Syrian hamsters. We define mechanisms by which N and Gn proteins inhibit RIG-I/TBK1 signaling pathways
and identify mutations that abolish regulation. We evaluate ANDV reassortants and mutants for attenuation in a
lethal Syrian hamster HPS disease model.
We define HV virulence determinants by identifying N/Gn residues of ANDV, MAPV & SNV required to
regulate RIG-I/TBK1/IRF3 signaling pathways. We analyze ANDV regulation of IFN inductionin ECs, ANDV N
regulation of TRIM21, and N/Gn synergy in IFN regulation. ANDV/MAPV reassortants and N/Gn-ΔIFN rANDV
mutants are evaluated for their attenuation and ability to protect Syrian hamsters from Wt ANDV infection.
期刊论文(6)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Measuring Transendothelial Electrical Resistance (TEER) for Dengue Infection Studies.
测量跨内皮电阻 (TEER) 以进行登革热感染研究。
DOI:
10.1007/978-1-0716-1879-0_13
发表时间:
2022
期刊:
Methods in molecular biology (Clifton, N.J.)
影响因子:
--
作者:
[Conde,JonasNascimento, Mladinich,Megan, Schutt,William, Mackow,ErichR]
通讯作者:
Mackow,ErichR
DOI:
10.1128/mbio.03185-20
发表时间:
2020-12-11
期刊:
mBio
影响因子:
6.4
作者:
[Nascimento Conde J, Schutt WR, Gorbunova EE, Mackow ER]
通讯作者:
Mackow ER
Novel infection of pericytes by Andes virus enhances endothelial cell permeability.
安第斯病毒对周细胞的新感染增强了内皮细胞的通透性。
DOI:
10.1016/j.virusres.2021.198584
发表时间:
2021
期刊:
Virus research
影响因子:
5
作者:
[Perez,RamonD, Gorbonova,ElenaE, Mackow,ErichR]
通讯作者:
Mackow,ErichR
DOI:
10.1128/mbio.00952-17
发表时间:
2017-07-11
期刊:
mBio
影响因子:
6.4
作者:
[Mladinich MC, Schwedes J, Mackow ER]
通讯作者:
Mackow ER
Novel Hantavirus Virulence Determinants
-
批准号:9330296
-
项目类别:
-
资助金额:$66.59万
-
财政年份:2016
-
负责人:Erich R Mackow
-
依托单位:
Dengue Infected Endothelial Cells Enhance Immune Cell Activation
-
批准号:8385024
-
项目类别:
-
资助金额:$19.63万
-
财政年份:2012
-
负责人:Erich R Mackow
-
依托单位:
Dengue Infected Endothelial Cells Enhance Immune Cell Activation
-
批准号:8495920
-
项目类别:
-
资助金额:$22.21万
-
财政年份:2012
-
负责人:Erich R Mackow
-
依托单位:
ANDV Induced Responses of Hypoxic Endothelial Cells
-
批准号:8190126
-
项目类别:
-
资助金额:$19.63万
-
财政年份:2011
-
负责人:Erich R Mackow
-
依托单位:
Therapeutic Interventions Against ANDV Induced Pathogenesis
-
批准号:8385518
-
项目类别:
-
资助金额:$41.81万
-
财政年份:2011
-
负责人:Erich R Mackow
-
依托单位:
Therapeutic Interventions Against ANDV Induced Pathogenesis
-
批准号:8581639
-
项目类别:
-
资助金额:$44.57万
-
财政年份:2011
-
负责人:Erich R Mackow
-
依托单位:
ANDV Induced Responses of Hypoxic Endothelial Cells
-
批准号:8264741
-
项目类别:
-
资助金额:$23.55万
-
财政年份:2011
-
负责人:Erich R Mackow
-
依托单位:
Therapeutic Interventions Against ANDV Induced Pathogenesis
-
批准号:8237655
-
项目类别:
-
资助金额:$44.99万
-
财政年份:2011
-
负责人:Erich R Mackow
-
依托单位:
Determinants of Pathogenic Hantavirus Attachment
-
批准号:7860323
-
项目类别:
-
资助金额:$19.61万
-
财政年份:2009
-
负责人:Erich R Mackow
-
依托单位:
Recombinant ANDV: IFN Regulation Knockout
-
批准号:7943379
-
项目类别:
-
资助金额:$22.71万
-
财政年份:2009
-
负责人:Erich R Mackow
-
依托单位:
Determinants of Pathogenic Hantavirus Attachment
-
批准号:7571337
-
项目类别:
-
资助金额:$23.4万
-
财政年份:2009
-
负责人:Erich R Mackow
-
依托单位:
Influenza PDZ Ligand Directed Pathogenesis
-
批准号:7472546
-
项目类别:
-
资助金额:$22.81万
-
财政年份:2007
-
负责人:Erich R Mackow
-
依托单位:
Influenza PDZ Ligand Directed Pathogenesis
-
批准号:7294984
-
项目类别:
-
资助金额:$19.38万
-
财政年份:2007
-
负责人:Erich R Mackow
-
依托单位:
Cellular Determinants of Hantavirus Pathogenesis
-
批准号:6730801
-
项目类别:
-
资助金额:$41.71万
-
财政年份:2003
-
负责人:Erich R Mackow
-
依托单位:
HANTAVIRUS CELL INTERACTIONS
-
批准号:6166280
-
项目类别:
-
资助金额:$26.34万
-
财政年份:2000
-
负责人:Erich R Mackow
-
依托单位:
HANTAVIRUS CELL INTERACTIONS
-
批准号:6603595
-
项目类别:
-
资助金额:$26.34万
-
财政年份:2000
-
负责人:Erich R Mackow
-
依托单位:
HANTAVIRUS CELL INTERACTIONS
-
批准号:6511460
-
项目类别:
-
资助金额:$26.34万
-
财政年份:2000
-
负责人:Erich R Mackow
-
依托单位:
HANTAVIRUS CELL INTERACTIONS
-
批准号:6374562
-
项目类别:
-
资助金额:$26.34万
-
财政年份:2000
-
负责人:Erich R Mackow
-
依托单位:
ROTAVIRUS VP5 PERMEABILIZES MEMBRANES
-
批准号:6534140
-
项目类别:
-
资助金额:$21.18万
-
财政年份:1999
-
负责人:Erich R Mackow
-
依托单位:
ROTAVIRUS VP5 PERMEABILIZES MEMBRANES
-
批准号:2827242
-
项目类别:
-
资助金额:$19.38万
-
财政年份:1999
-
负责人:Erich R Mackow
-
依托单位:
海外基金